Device Orthodontics

Itero Lumina Cart Configuration

Payments companies reported to CMS as associated with Itero Lumina Cart Configuration. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$97Kassociated payments (2023-2025)
17clinicians with associated payments
1company reporting

By year

2024 $34K
2025 $63K

Payments reported as associated with Itero Lumina Cart Configuration, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthodontics and Dentofacial Orthopedics $49K
Dentist $21K
General Practice (Dentist) $20K
Periodontics $3,767
Pediatric Dentistry $2,583

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Itero Lumina Cart Configuration

These are the largest totals companies reported as associated with Itero Lumina Cart Configuration. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Zachary Casagrande Reston, VA Dentist $14,083.34
Daniel Lill Winchester, VA Orthodontics and Dentofacial Orthopedics $10,333.34
Regina Blevins Woodbury, MN Orthodontics and Dentofacial Orthopedics $10,233.33
Ryan Molis Burr Ridge, IL General Practice (Dentist) $8,066.67
Mazyar Moshiri Saint Louis, MO Orthodontics and Dentofacial Orthopedics $7,383.34
Jonathan Nicozisis Princeton, NJ Orthodontics and Dentofacial Orthopedics $7,316.67
Corey Anolik Philadelphia, PA General Practice (Dentist) $6,466.67
Richard Jacobson Pacific Palisades, CA Orthodontics and Dentofacial Orthopedics $5,600.00
Joshua Adcox Temple, TX General Practice (Dentist) $5,566.67
Kinnith Morris Cincinnati, OH Orthodontics and Dentofacial Orthopedics $4,566.67

Prescribed Itero Lumina Cart Configuration?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.